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Abstract 
The coronavirus epidemic has become one of the major health concerns all over the world recently. Like other strains of 
coronavirus, this strain also spreads through a droplet-based transmission that is the main cause of its worldwide spread. 
Several trials of antiviral medicines related to the control of the virus have already begun globally but still one of the 
main problems is the lack of a viable treatment option. An extensive amount of research is still taking place to organize 
the data associated with genomics and proteomics of its original strain SARS-CoV-2 alongside other mutant strains. 
This review summarizes the related up-to-date research that is going on the structural organization of the genome and 
proteome of the virus. 
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Introduction 
The recent novel coronavirus belongs to the family 
of viruses called Coronaviridae that belongs to the 
order Nidovirales. It is an enveloped RNA virus. 
RNA present in this virus is single-stranded and 
positive sense. It has also been revealed on 
extensive phylogenetic analysis that it resembles 
96.2% of the strain of coronaviruses found in bats 
(1). It spreads by respiratory droplets resulted in 
sneezing, cough and contact that may be direct or 
indirect. This droplet-based mode of transmission 
has been recently confirmed by modern researchers 
(30). It causes severe respiratory syndrome and 
attacks the same receptor site angiotensin-
converting enzyme 2 (ACE2) (2).  
The most important and obvious genomic 
characters of SARS CoV-2 include its binding with 
the human ACE2 receptor site and the other is its 
extensive arrangement of outside spike proteins (3). 
It is the seventh strain of coronavirus from its 
family that causes infectious diseases in human 
beings (4). It varies from spherical to pleomorphic 
forms with a length ranging from 80-160 nm. It 
comprises four structural proteins, which are Spike 
(S), Nucleocapsid (N), Envelope (E), and 
Membrane (M) that resembles both in structure and 
function with other members of its family. All of 
these proteins are responsible for a stable shape as 
well as exceptional virulent characters of the virus 
(5). 
Genome and its organization 
The genetic material of SARS CoV-2 is composed 
up of single-stranded positive-sense RNA having 
approximately 30,000 bases dispersed in a complex 
arrangement. The total number of nucleotides that 
the whole genome consists of is 29891 revealed 
after rigorous bioinformatics analysis. The 
percentage abundance of overall GC content is 
38%. Its genome encodes 9860 total amino acids by 
utilizing the basic central dogma pathway. 
Functional open reading frames (ORFs) are 12 in 
number that is essential for proper replication of the 
virus. The sub-genomic mRNAs have a variety of 
conserved sequences out of which 9 are 
transcription-regulatory sequences and there are 
only two terminal UTRs (6). Its genome does not 
have a haemagglutinin-esterase gene found in other 
members of beta coronaviruses (7).  
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ORF1 has conserved about 66% of the total genome 
of the virus that is essential for the encoding of 
pp1a and pp1ab precursor proteins. It also translates 
16 more NSP non-structural proteins. Other ORFs 
encode crucial elementary and other supplementary 
structural proteins. NSP includes viral cysteine 
proteases called NSP3 and NSP5, RNA associated 
RNA polymerase NSP13, and remaining NSPs, 
which play important functions in transcription and 
duplication and ultimately the whole replication 
process (8).  
The genome organization of SARS-CoV-2 has been 
presented in figure 1 (9). The remaining viral genes 
encode S, M, E, and N proteins. The organization of 
the genome is 5’-leader-UTR-replicase-Spike-
Envelope-Membrane-Nucleocapsid-3’UTR-polyA 
tail having basic genes that are structurally 
associated at the 3’ end (29). 
 
 
Figure 1. Organization of SARS-CoV-2 genome. Two large genes ORF1a (yellow) and ORF1b (blue). 
Structural proteins S, E, M, and N (Green). Accessory proteins (Gray Shading) (29). 
Proteomics 
There are four important structural proteins named 
S, E, M, and N proteins. They play different roles 
from shape maintenance to genome replication. All 
of these proteins are necessary to be present for the 
proper implication of each function. As we already 
know that SARS CoV-2 contains 12 functional 
ORFs in its genome which encodes different crucial 
proteins to enable the virus for the replication 
process (6, 10).  
Terminal ORFs i.e., 1a and 1b generate a replicase 
gene, which is responsible for the transcription of 
pp1a and pp1ab having a size of 450 kD and 
750 kD respectively. NSPs are proteolyzed by viral 
proteases and it is one of the most important steps 
in the replication process (11). Papain-like cysteine 
protease plays a vital role in the cleavage process of 
pp1a and pp1ab. Chymotrypsin like protease gives 
multi-subunits protein known as viral replicase-
transcriptase (12). This is classified as 3C-like 
protease and, shortly written as 3CLpro because of 
its connection with 3C protease of β-coronaviruses 
(13). 3CLpro is a basic protease required for 
coronaviruses associated polyprotein cleavage and 
it controls the actions of replication complexes that 
are involved. 3CLpro is also known as the main 
protease, M-pro. It has become a focus of interest 
because of its inevitable part in the life cycle of 
viruses so that antivirals can be generated from the 
overall analysis of its kinetics (12). 
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Spike (S) protein is a type 1 membrane glycoprotein 
and it has two major domains to form its structure. 
The Ecto-domain is N-terminal linked and cysteine-
rich domain is C-terminal linked. Translation of S 
protein occurs on specific regions of polysomes and 
then it is pushed into the rough endoplasmic 
reticulum where glycosylation and transfer to the 
Golgi complex take place. Viral particles are 
inserted during this overall movement. Other S 
particles that are free from the virus are pushed 
towards the membrane. S protein interacts with the 
receptor and starts viral entrance into the host cell 
(14). It comprises about 1273 amino acids 
lengthwise. It has 13 amino acids as signal peptides 
at N-terminal. C-terminus has 28 residues as a 
cytoplasmic tail (15). It is encoded in the form of a 
lengthy chain that is broken down into two linked 
subunits S1 and S2. S1 is termed as a marginal part 
and S2 is known to be a membrane-spanning 
subunit. Both of them cause cell fusion. They are 
believed to be involved in the initiation of their 
infectious process (16). N protein is a structural 
protein that is responsible for the identification of 
RNA stretches that ultimately generate signals and 
helps in the synthesis of ribonucleoprotein (RNP). 
N protein covers genomic RNA and forms a stable 
helical structure. The helical nucleocapsid is always 
transformed into a core having a characteristic 
icosahedral symmetry. It has 422 basic amino acids 
that are responsible for the overall basic charge. It 
has a low homological match-up with other 
coronaviruses (17). N protein has two major 
functions which are biochemical and 
thermodynamic (18). N protein can be easily 
denatured because it has no high permanency (19). 
N-Terminal domain of M protein is always present 
on the surface of the virus and C-Terminus is open 
to the inner surface. It has a hydrophobic 
transmembrane that is comprised up of 12-37 
characteristic residues. SMWSFNPE is a 
specifically conserved sequence present right after 
the end of hydrophobic transmembrane.  It is the 
most abundant polypeptide present in the virus. 
Moreover, it is an elementary and basic component 
in the assembly and morphogenesis of viruses (20). 
It is also involved in forming the stable shape of the 
virus. The E proteins in different viruses of 
coronaviridae have a different structure but there is 
always some similarity in them (21). E proteins vary 
from 76-109 amino acids in size. It is the smallest 
protein in the genome of coronavirus (31). It has 
also a basic role in the formation of the envelope. E 
proteins are present in the intracellular membrane 
having C-terminus protruding to the cytoplasmic 
region in the target cell. The N-terminus is crusted 
in the membrane by 2/3 lengthwise (22). Studies 
show that E forms ion channels in the lipid bilayer 
of the membrane for monovalent cations selectively 
(23). It also adjusts cell membrane penetrability that 
is good for the replication of the virus in host cells. 
E type of proteins also demonstrates their role in 
viral replication (24, 32). 
NSPs (Non-Structural Proteins) 
The 5’-terminal two-third consists of the viral 
replicase gene, which in turn translates two large 
polyproteins pp1a and pp1ab. Pp1a shifts the 
ribosome into -1 upstream of the open reading 
frame (ORF) 1a where the termination codon is 
located. Proteolytic cleavage of polyproteins is 
courtesy of many non-structural viral proteins. 
NSPs also have a part in the replication and 
transcription of mRNAs ORF1 downstream process 
of replication. Proteases like 3CLpro and PL2pro 
are always represented by NSP5 and NSP3 
respectively (10). PL2pro cuts at 3 characteristic 
sites and 3CLpro cuts polyproteins at 11 sites 
producing 16 NSPs at the end (24, 32). 
Life Cycle Junctures  
SARS CoV-2 has an exceptional replication process 
(Figure 2). It has different stages that are involved 
in the successful replication of the virus. It infects 
cells either by endosome or plasma membrane 
implication. Spike proteins S1 and S2 initiate 
attachment of the virus to the target cell by 
appealing the ACE2 site as their receptor (25). 
Virus after finishing entry tries to activate the spike 
proteins by signaling Cathepsin L that initiated the 
fusion process. Viral membrane fuses with the host 
cell membrane by cellular serine protease 
TMPRSS2 (25). Because of plasma membrane 
fusion, the host cell is now deprived of immunity 
against the virus (26). After the entry and 
attachment of the virus, it is time to synthesize viral 
polyproteins that takes the process even further.  
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Viral genomic RNA translates NSPs which have a 
critical role in RNA synthesis. Pp1a and pp1ab are 
proteolyzed into functional NSPs like helicase and 
RNA-replicase-transcriptase complex (27). 
 
 
Figure 2. Host cells displaying the life cycle of SARS-CoV-2 (29). 
Replication of spike, envelope, membrane, and 
nucleocapsid proteins is completed by the RdRp 
complex. They are translated by ribosomes and 
localized on the reticulum for assembly of the virus. 
The N protein remains in the cytoplasm for 
assembly with RNA. Virion precursors are exposed 
to N proteins and then they are moved through ER 
and Golgi complex by small vesicles. Now, the 
viruses inside the cell are in full mature form. All of 
these mature viruses are expelled out of the 
damaged cell via the process of exocytosis and 
again these newly produced viruses begin to search 
for a new target host cell where it can start the 
replication process again (28, 29). 
Conclusion 
All of this data is obtained from the initial 
researches that have been performed by several 
different research institutes internationally. 
However, this is a major issue of health concern 
around the globe nowadays, and more and more 
accurate and modern methods of research have been 
applied by the researchers by utilizing modern 
technology to construct a more accurate map of 
proteome and genome of SARS-CoV-2 is still in 
development. Hopefully, we may see better and 
more up-to-date research on the organization of the 
genome and proteome of SARS-CoV-2 in the 
future.  
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